Japan's photography and imaging company Fujifilm Holdings Corp, today offered to buy US-based ultrasound and cardiograph equipment maker SonoSite Inc, for about $753 million in cash.
Tokyo-based Fujifilm, through its US subsidiary, will offer $54 per share in cash, a premium of 75.4 per cent over the closing price of SonoSite on 2 November, the last trading day before news agencies reported a potential transaction.
SonoSite is a world leader in point-of-care ultrasound products. It specialises in the development of ultra portable and other devices that are used in more than 20 clinical specialties.
The Bothell, Washington-based company also recently expanded into the pre-clinical research market with its newly acquired ultra-high frequency micro-ultrasound technology.
SonoSite's products are designed for applications where ultrasound has not typically been used, such as emergency medicine, surgery, critical care, internal medicine, musculoskeletal, and vascular access procedures, as well as for imaging in traditional applications, such as radiology, cardiology, vascular medicine, and obstetrics and gynecology.
The company has 14 subsidiaries and a global distribution network in over 100 countries.